Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
NCT Number: NCT03265431
This study is performed to assess if PET-MR imaging can improve treatment of patients with irregular heart rate and heart failure. Heart failure occurs when the heart muscle is too weak to do his work correctly. Irregular heart rate can be related to numerous diseases. One category of irregular heart rate is called ventricular arrhythmia. It is often seen in patients who have had a heart attack. This type of arrhythmia can be dangerous and can cause sudden death. To prevent these arrhythmias, doctors can perform procedures that burn the source of arrhythmia in the heart muscle. This is called ablation. Unfortunately, ablation does not fix the problem in 100% of patients and some will still have the arrhythmia requiring repeated procedure. The purpose of this study is to find new ways of guiding the doctors performing ablation, hoping to improve the success rate of the procedure.
This study is active but is not currently recruiting participants.
21 year–80 year
All sexes
Interventional
Phase 2
Boston, Massachusetts, 02114, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Healthy Volunteers
Inclusion criteria
Exclusion criteria
Arrhythmia Subjects:
Inclusion criteria
Exclusion criteria
Imaging with 18-F-TPP (18F-BFPET)
Other names: 18F-BFPET
Time frame: 5 years
Establish imaging patterns allowing prediction of VT ablation failure
Massachusetts General Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05855135
Arrhythmias, Cardiac, CCM Therapy
Glendale, Arizona, United States
View Trial DetailsNCT05498376
Arrhythmias, Cardiac, Atrioventricular Block
Bern, Switzerland
View Trial DetailsNCT07276139
Arrhythmias, Cardiac, Cardiomyopathies
Bern, Switzerland
View Trial DetailsNCT04464499
Arrhythmias, Cardiac, Atrial Fibrillation
Bagnolet, France
View Trial Details